Tomer Adar

Tomer Adar

Auto-generated profile, based on publicly available information

Tomer Adar

Gastroenterology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2018 in Cancer
Verified
Journal Article
Closed access
PDF file
TATomer Adar
Tomer Adar
LRLinda H. Rodgers
Linda H. Rodgers
KSKristen M. Shannon
Kristen M. Shannon
MYMakoto Yoshida
Makoto Yoshida
TMTianle Ma
Tianle Ma
DCDaniel C. Chung
Daniel C. Chung

1 February 2016 in European Journal of Inflammation
Verified
Journal Article
Open access
TATomer Adar
Tomer Adar
YEYair Edden
Yair Edden
SSShimon Shteingart
Shimon Shteingart
AYAmi Ben Ya'acov
Ami Ben Ya'acov
MMMahmud Mahamid
Mahmud Mahamid
EGEran Goldin
Eran Goldin
Portal hypertension is a complication of liver cirrhosis. The portal vein drains the spleen and the intestines, which are both rich in inflammatory mediators. Portal hypertension- induced stress within these organs that may result in pro-inflammatory changes. The association of these changes with regulatory T cells was not addressed before. Our aim is to investigate the involvement of some subsets of regulatory T cells in portal hypertension. In the current study we used the partial portal vein ligation model to demonstrate differences in the distribution of regulatory T cells within the portal vein and the inferior vena cava associated with portal hypertension. We show that CD4+CD25+FoxP3+ regulatory T cells are significantly (P <0.05) increased only in the inferior vena cava of partial portal vein ligation-rats. The development of portal hypertension was associated with the reversal of the distribution patterns in the portal vein and inferior vena cava for both CD4+ and CD8+ cells. We further show that in naïve rats CD4+IL17+ cells were significantly (P <0.05) and specifically enriched in inferior vena cava compared to the portal vein. These novel findings support the involvement of regulatory T cells in the inflammatory signals accompanied with acute portal hypertension.